HETEROCYCLIC COMPOUNDS AS IMAGING PROBES OF TAU PATHOLOGY

Pyridazinone compounds of Formula I: (I) wherein: R′ is alkyl or Ar, optionally substituted with at least one alkyl, halogen, hydroxyl, alkoxy, haloalkoxy, acid, ester, amino, nitro, amide, or alkoxyhalo; 2 R is independently alkyi, alkynyl, ester, amino, amide, acid, aryl, heteroaryl, aminoalkyl, -...

Full description

Saved in:
Bibliographic Details
Main Authors MOKKAPATI UMAMAHESHWAR P, JONES CLARE, NEWINGTON IAN MARTIN, JOSE JINTO, JOHANSSON SAGA, GLASER MATTHIAS EBERHARD, WYNN DUNCAN, RANGSWAMY CHITRALEKHA, NAIRNE JAMES
Format Patent
LanguageEnglish
Published 01.01.2015
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Pyridazinone compounds of Formula I: (I) wherein: R′ is alkyl or Ar, optionally substituted with at least one alkyl, halogen, hydroxyl, alkoxy, haloalkoxy, acid, ester, amino, nitro, amide, or alkoxyhalo; 2 R is independently alkyi, alkynyl, ester, amino, amide, acid, aryl, heteroaryl, aminoalkyl, -C(=0)alkyl, -C(=0)aryl, -C(=0)heteroaryl, -C(=0)heterocycloalkyl, -C(=0)heterocycloalkylAr, -C(=0)(CH2)nhalo, -C( O)(CH2)nheterocyclyl, or -SĈAr, optionally substituted with at least one alkyi, alkylhalo, halogen, nitro, aryl, heteroaryl, or heteroaryl(CH2)nhalo; R3 and R4 are independently hydrogen, alkyi, alkenyl, alkynyl, aryl, heteroaryl; Ar is an aryl, heteroaryl, cycloalkyl, heterocycloalkyl group; n is an integer from 0-10; or a radiolabeled derivative thereof. The compounds are useful as imaging probes of Tau pathology in Alzheimer's disease are described. Compositions and methods of making such compounds are also described.
Bibliography:Application Number: US201214365652